Alia Durrani, MD
Retina Specialist · Brentwood, MONPI 1841558822
Payments from drug & device makers
Across 181 payments — averaging $7089.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ocular Therapeutix, Inc.$1.2M
- Regeneron$74K
- Regeneron Healthcare Solutions, Inc.$32K
- Bausch & Lomb Americas Inc.$4K
- Genentech USA, Inc.$3K
- Eyepoint US, Inc.$2K
- plus $2K from 14 others
Across 1 payment — averaging $9600.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ocular Therapeutix, Inc.$10K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ocular Therapeutix, Inc. | 47 | $1,165,947 |
| Regeneron | 32 | $73,720 |
| Regeneron Healthcare Solutions, Inc. | 32 | $32,415 |
| Bausch & Lomb Americas Inc. | 6 | $4,331 |
| Genentech USA, Inc. | 15 | $3,118 |
| Eyepoint US, Inc. | 2 | $2,018 |
| Astellas Pharma US Inc | 12 | $424 |
| Novartis | 7 | $226 |
| Alimera Sciences, Inc. | 8 | $209 |
| ANI Pharmaceuticals, Inc. | 2 | $154 |
| Harrow Eye, LLC | 2 | $144 |
| Apellis Pharmaceuticals, Inc. | 1 | $132 |
| Carl Zeiss Meditec, Inc. | 3 | $131 |
| AbbVie(2 entities) | 5 | $85 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $27 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Biogen | 1 | $18 |
| Gilead | 1 | $17 |
| Alcon | 1 | $15 |
How this compares
$1,283,170 in reported general payments places this provider in the 95th percentile of 45 retina specialist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Brentwood
- Kevin BlinderBrentwood$2.2M
- Sabin DangBrentwood$486K
- Athanasios PapakostasBrentwood$262K
- Bradley SmithBrentwood$113K
- Avinash HonasogeBrentwood$51K
- Barton BlackorbyBrentwood$31K
- Ollya FromalBrentwood$14K
- Nicholas IafeBrentwood$9K
- Dillan PatelBrentwood$5K
- William AndersonBrentwood$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.